New 2019 Product & Service Catalogs

INVIVOSCRIBE

2019 Product & Services Catalogs

Now available in Digital PDF & NEW Digital Flipbook formats

INVIVOSCRIBE

2019 Product & Services Catalogs

Now available in Digital PDF & NEW Digital Flipbook formats

Digital PDF

Digital Flipbook

Digital PDF

Download The 2019 Product Catalog
(Digital PDF)

DOWNLOAD (PDF)

Download The 2019 Services Catalog
(Digital PDF)

DOWNLOAD (PDF)

Digital Flipbook

View The 2019 Product Catalog
(Digital Flipbook)

Invivoscribe-NEW-2019-Product-Catalog-Cover-Image-002

VIEW DIGITAL FLIPBOOK

View The 2019 Services Catalog
(Digital Flipbook)

Invivoscribe-NEW-2019-Services-Catalog-Cover-Image-002

VIEW DIGITAL FLIPBOOK

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

March 1st, 2024 Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

March 1st, 2024 Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

January 25th, 2024 Leveraging Standardized MRD Assays to Guide CLL Treatment

March 23rd, 2023 Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

INVIVOSCRIBE

2019 Product & Services Catalogs

Now available in Digital PDF & NEW Digital Flipbook formats

INVIVOSCRIBE

2019 Product & Services Catalogs

Now available in Digital PDF & NEW Digital Flipbook formats

Digital PDF

Digital Flipbook

Download The 2019 Product Catalog (Digital PDF)

Download The 2019 Services Catalog (Digital PDF)

View The 2019 Product Catalog (Digital Flipbook)

View The 2019 Services Catalog (Digital Flipbook)

Digital PDF

Download The 2019 Product Catalog (Digital PDF)

Download The 2019 Services Catalog (Digital PDF)

Digital Flipbook

View The 2019 Product Catalog (Digital Flipbook)

View The 2019 Services Catalog (Digital Flipbook)

Title

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

Download The 2019
Product Catalog
(Digital PDF)

Download The 2019
Services Catalog
(Digital PDF)

View The 2019
Product Catalog
(Digital Flipbook)

View The 2019
Services Catalog
(Digital Flipbook)

Download The 2019 Product Catalog
(Digital PDF)

Download The 2019 Services Catalog
(Digital PDF)

View The 2019 Product Catalog
(Digital Flipbook)

View The 2019 Services Catalog
(Digital Flipbook)